Next Dimension unveils 3-D software

Article

Software developer Next Dimension Imaging this month introduced a line of clinical cardiology software based on 3-D ultrasound imaging methods. Out of its R&D in cardiac imaging, the company has developed OEM software toolkits that it licenses to

Software developer Next Dimension Imaging this month introduced a line of clinical cardiology software based on 3-D ultrasound imaging methods. Out of its R&D in cardiac imaging, the company has developed OEM software toolkits that it licenses to companies with 3-D products. Next Dimension has developed a range of clinical products with its toolkits intended to enhance the efficiency of 3-D ultrasound systems.

The company’s 3-D PlaneView and 3-D LV-View both use a plane-reconstruction engine for stacks of nonparallel images common in 3-D ultrasound acquisition. With 3-D LV-View, physicians can track the morphology and mobility of cardiac tumors and masses through virtual object modeling.

Next Dimension of Longmont, CO, was founded in 1996 by Lothar Muench and is relatively new to software development. In the past, the company has primarily offered consulting services for 3-D acquisition, processing, visualization, and OEM software.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.